Send us Feedback

Rochester Medical (ROCM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

 
Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Apr 25, 2013)
  • 8-K (Feb 1, 2013)
  • 8-K (Jan 29, 2013)
  • 8-K (Dec 28, 2012)
  • 8-K (Dec 18, 2012)
  • 8-K (Nov 27, 2012)

 
Other

Rochester Medical 8-K 2012

Documents found in this filing:

  1. 8-K
  2. Ex-10.1
  3. Ex-10.2
  4. Ex-10.3
  5. Ex-10.3
Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 26, 2012

 

 

ROCHESTER MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Minnesota   0-18933   41-1613227

(State or other jurisdiction

of incorporation)

  

(Commission

file number)

  

(I.R.S. Employer

Identification No.)

One Rochester Medical Drive, Stewartville, MN 55976

(Address of principal executive offices)

Registrant’s telephone number, including area code: (507) 533-9600

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 26, 2012, the Compensation Committee of the Board of Directors of the Company approved forms of Restricted Stock Award Agreements for use in connection with grants of restricted stock to employees and non-employee directors, and form of Restricted Stock Unit Award Agreement for use in connection with grants of restricted stock units to employees under the Company’s 2010 Stock Incentive Plan, which are attached hereto as Exhibits 10.1, 10.2 and 10.3 and incorporated herein by reference.

Also on January 26, 2012, the Compensation Committee approved a grant of restricted stock units to each of the Company’s executive officers. Such units will vest at the end of fiscal year 2013, based upon the achievement of corporate goals for fiscal 2013 operating income as determined by the Compensation Committee.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On January 26, 2012, Rochester Medical Corporation (the “Company”) held its 2012 Annual Meeting of Shareholders. There were 12,043,167 shares of common stock entitled to vote at the meeting; 10,968,177 shares were represented at the meeting in person or by proxy. The Company’s shareholders voted on the following matters:

 

1. The election of five directors to serve until the next Annual Meeting of Shareholders;

 

2. The ratification of the selection of Grant Thornton LLP as the Company’s independent auditor for the fiscal year ending September 30, 2012; and

 

3. An advisory vote on a non-binding resolution to approve the compensation of the Company’s executives disclosed in the proxy statement for the 2012 Annual Meeting.

The results of the shareholder votes are set forth below:

Board of Directors.

 

Nominees

    For      Withheld      Broker Non-Votes  

Darnell L. Boehm

      6,278,491         173,845         4,515,841   

Anthony J. Conway

      6,217,891         234,445         4,515,841   

David A. Jonas

      6,136,841         315,495         4,515,841   

Peter H. Shepard

      6,285,521         166,815         4,515,841   

Benson Smith

      6,205,541         246,795         4,515,841   

Independent Auditor.

 

For

    Against      Abstain      Broker Non-Votes  

10,698,608

      245,604         23,965         0   

Approval, on an Advisory Basis, of Executive Compensation.

 

For

    Against      Abstain      Broker Non-Votes  

5,179,746

      138,107         1,134,483         4,515,841   

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

10.1*    Form of 2010 Stock Incentive Plan Restricted Stock Award Agreement for employees
10.2*    Form of 2010 Stock Incentive Plan Restricted Stock Award Agreement for directors
10.3*    Form of 2010 Stock Incentive Plan Restricted Stock Unit Award Agreement for employees

 

* Indicates management contract, compensatory plan or arrangement required to be filed pursuant to Item 601(b)(10)(iii)(A) of Regulation S-K.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Date: January 30, 2012

 

ROCHESTER MEDICAL CORPORATION
By:  

/s/ David A. Jonas

 

David A. Jonas

Chief Financial Officer

 

EXHIBIT INDEX

 

Exhibit No.

   

Description

10.1*    Form of 2010 Stock Incentive Plan Restricted Stock Award Agreement for employees
10.2*    Form of 2010 Stock Incentive Plan Restricted Stock Award Agreement for directors
10.3*    Form of 2010 Stock Incentive Plan Restricted Stock Unit Award Agreement for employees

 

* Indicates management contract, compensatory plan or arrangement required to be filed pursuant to Item 601(b)(10)(iii)(A) of Regulation S-K.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki